Categories: News

BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Pekka Jalovaara

BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST)

BBS-Bioactive Bone Substitutes Oyj Managers’ Transactions – Pekka Jalovaara

This Company announcement contains information on the following management transactions:

  • Subscription of shares with warrants (TO1) 5 December 2022
  • Subscription of shares with warrants (TO2) 29 May 2023
  • Subscription of shares in share issue on 26 June 2023
  • Received shares without consideration on 11 July 2023 (directed share issue without consideration, release 7 June 2023)

____________________________________________

Person subject to the notification requirement

Name: Jalovaara Pekka

Position: Member of the Board/Deputy member

Issuer: BBS Bioactive Bone Substitutes Oyj

LEI: 743700BYSBP0PCR6N767

Notification type: INITIAL NOTIFICATION

Reference number: 743700BYSBP0PCR6N767_20230803191449_6

____________________________________________

Transaction date: 2022-12-05

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 1,925 Unit price: 0.92 EUR

Aggregated transactions

(1): Volume: 1,925 Volume weighted average price: 0.92 EUR

____________________________________________

Transaction date: 2023-05-29

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 1,925 Unit price: 0.65 EUR

Aggregated transactions

(1): Volume: 1,925 Volume weighted average price: 0.65 EUR

____________________________________________

Transaction date: 2023-06-26

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 7,200 Unit price: 0.5 EUR

(2): Volume: 4,020 Unit price: 0.5 EUR

Aggregated transactions

(2): Volume: 11,220 Volume weighted average price: 0.5 EUR

____________________________________________

Transaction date: 2023-07-11

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: OTHER

Description: Received shares without consideration on 11 July 2023 (directed share issue without consideration, release 7 June 2023)

Transaction details

(1): Volume: 385 Unit price: 0.00 EUR

Aggregated transactions

(1): Volume: 385 Volume weighted average price: 0.00 EUR

____________________________________________

Contact information:

Ilkka Kangasniemi, CEO
040 708 0307
ilkka.kangasniemi@bbs-artebone.fi

Staff

Recent Posts

Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock

PALO ALTO, Calif., Dec. 16, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial…

52 minutes ago

Nested Knowledge and Pharmacy Podcast Network Announce Strategic Collaboration to Advance Evidence-Based Podcasting in Healthcare

New partnership combines AI-powered evidence synthesis with trusted pharmacist-led audio content to elevate clinical education…

52 minutes ago

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…

7 hours ago

2026 Brings Sharp 21% Spike in Health Insurance Premiums – Squeezing Household Budgets

ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…

7 hours ago

Bioassay Method Transfer Strategies to Reduce Variability, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to identify sources of variability in bioassay method transfers…

7 hours ago